Congressional Briefing on HPV-Related Cancers
Presented by the American Association for Cancer Research (AACR), Moffitt Cancer Center and Biden Cancer Initiative in partnership with the American Cancer Society Cancer Action Network (ACS CAN), American Society of Clinical Oncology (ASCO), Association of American Cancer Institutes (AACI), Prevent Cancer Foundation, St. Jude Children’s Research Hospital, and the Union for International Cancer Control (UICC).
**Call to Action on the Elimination of HPV-related Cancers**
LET’S END HPV-RELATED CANCERS
Thursday, June 27, 2019
Noon – 1:30 p.m. ET
Rayburn House Office Building, Room 2044
View Flyer *To view presentations, click on speaker's name below
Cancers caused by human papillomavirus (HPV) represent a significant disease burden in the United States and globally. Over 33,000 HPV-related cancers are diagnosed annually among men and women in the U.S. alone. Globally, 630,000 cases of HPV-related cancers are diagnosed each year.
Due to advances in vaccination, screening and treatment, the elimination of cervical cancer – and ultimately all HPV-related cancers – is within reach. However, this goal will require a strong commitment from governments, public health organizations, health care workers, parents and other stakeholders in the U.S. and around the world. During this important congressional briefing, speakers representing a diverse range of expertise in domestic and global health discussed current interventions against HPV-related cancers and what needs to be done to achieve elimination.
HONORARY CONGRESSIONAL COCHAIR
Gilbert S. Omenn, MD, PhD, Director, Center for Computational Medicine and Bioinformatics, University of Michigan; Chairman, Health Policy Subcommittee, American Association for Cancer Research
Anna R. Giuliano, PhD, Founding Director, Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center
John T. Schiller, PhD, NIH Distinguished Investigator; Deputy Chief, Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute
Melinda Wharton, MD, MPH, Director, Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention
Vicki Benard, PhD, Chief, Cancer Surveillance Branch, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention
Julie S. Torode, PhD, Director of Special Projects, Union for International Cancer Control (UICC)
Jason T. Mendelsohn, Patient Advocate and Survivor, SupermanHPV.com